Robert P. Roche Jr.

This profile gathers the share dealings of Robert P. Roche Jr. across 5 companies, led by Cephalon Inc, Antares Pharma, Inc. and Aratana Therapeutics, Inc. Over a trading history stretching from 19 December 2005 to 24 May 2022, the count stands at 138 filings.

On the open market, the record shows 5 purchases worth €75k and 63 sales worth €12.6M. Sales outweigh purchases by €12.6M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 29 share grants and 21 option exercises.

Half of the purchases are above €8,691 and half below.

The newest entry dates from 26 May 2022: a transaction of €258k, in Antares Pharma, Inc. The most recent open-market purchase was published on 22 March 2016, 3,867 days ago. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.